Bausch Health Companies (BHC) Amortizatization of Intangibles (2009 - 2012)
Bausch Health Companies (BHC) posted Amortizatization of Intangibles of $3.2 million for Q1 2012, up 63.51% sequentially from $2.0 million in Q4 2011, and up 22.98% YoY from $2.6 million in Q2 2011.
Bausch Health Companies (BHC) Amortizatization of Intangibles (2009 - 2012) Analysis & Trends
Bausch Health Companies has reported Amortizatization of Intangibles for 4 years, with the latest figure at $3.2 million in Q1 2012.
- Quarterly Amortizatization of Intangibles rose 22.98% year-over-year to $3.2 million in Q1 2012, while the trailing twelve-month figure through Mar 2012 was $9.1 million (down 17.37% YoY) and the FY2011 annual result came in at $8.5 million, down 23.98% from the prior year.
- Amortizatization of Intangibles rose to $3.2 million in Q1 2012 per BHC's latest filing, from $2.0 million in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $3.2 million in Q1 2012 and troughed at $564000.0 in Q2 2009.
- A 4-year average of $2.4 million and a median of $2.7 million in 2009 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2010 and 2011: Amortizatization of Intangibles soared 403.01% in 2010, then slumped 31.44% in 2011.
- Over 4 years, Amortizatization of Intangibles stood at $2.7 million in 2009, then gained by 2.88% to $2.8 million in 2010, then dropped by 29.51% to $2.0 million in 2011, then jumped by 63.51% to $3.2 million in 2012.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $3.2 million, $2.0 million, and $1.9 million for Q1 2012, Q4 2011, and Q3 2011 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Bausch Health Companies | 2.57 Bn | 734.50 Mn | 2.10 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2012 | 3.25 Mn |
| Mar 31, 2012 | 3.25 Mn |
| Dec 31, 2011 | 1.99 Mn |
| Dec 31, 2011 | 1.99 Mn |
| Sep 30, 2011 | 1.92 Mn |
| Sep 30, 2011 | 1.92 Mn |
| Jun 30, 2011 | 1.95 Mn |
| Jun 30, 2011 | 1.95 Mn |
| Mar 31, 2011 | 2.64 Mn |
| Mar 31, 2011 | 2.64 Mn |
| Dec 31, 2010 | 2.82 Mn |
| Dec 31, 2010 | 2.82 Mn |
| Sep 30, 2010 | 2.71 Mn |
| Sep 30, 2010 | 2.71 Mn |
| Jun 30, 2010 | 2.84 Mn |
| Jun 30, 2010 | 2.84 Mn |
| Mar 31, 2010 | 2.80 Mn |
| Mar 31, 2010 | 2.80 Mn |
| Dec 31, 2009 | 2.74 Mn |
| Dec 31, 2009 | 2.74 Mn |